 Solution

The Lgr5-expressing population is not always indispensable for short-term small-intestinal maintenance, but the unqualified claim of dispensability is misleading. Its contribution and its requirement depend on injury, timing, ablation efficiency and replacement by other cells. Three questions must be separated: whether Lgr5-expressing cells normally generate the epithelium, whether the Lgr5 receptor itself is necessary, and whether the tissue can replace the marker-defined cell state after its cells are removed.

In adult mouse small intestine, actively cycling crypt-base columnar cells include an Lgr5-expressing population that produces the major epithelial lineages. Inducible permanent lineage tracing from Lgr5-expressing cells generated long-lived epithelial contributions, demonstrating self-renewal and multilineage output. ^[ref] This identifies a functional stem-cell population under those conditions. It establishes normal contribution, however, not exclusive capacity or necessity. A lineage can supply most routine replacement while another population has latent capacity to take over after removal.

stem-cell ablation makes a different causal test. Engineering the human diphtheria toxin receptor into the Lgr5 locus allowed the marked population to be depleted. In the tested depletion regime, intestinal epithelial maintenance continued, and other cells could replace the missing stem-cell output; Bmi1-associated lineage experiments supported a reserve contribution. ^[ref] This result refutes a simple model in which immediate loss of all renewal must follow removal of the cycling Lgr5-positive compartment. It does not establish that no stem-like function is necessary, that the marker-defined state can never reappear, or that the same result holds indefinitely under every physiological challenge.

The relevant conclusion is about the experimental window and endpoint. Histologically recognizable crypts shortly after treatment are weaker evidence than sustained production of all lineages and preserved barrier or absorptive function. transit-amplifying cells and surviving differentiated cells can temporarily conceal a loss of long-term renewal. Conversely, if output continues beyond their expected persistence and previously unlabelled cells restore long-lived clones, genuine compensation is likely. Repeated observation should therefore quantify target-cell depletion, proliferation, crypt survival, lineage composition and the re-emergence of Lgr5 expression throughout treatment and recovery.

Interpretation also depends on whether reserve cells form a permanently distinct hierarchy or are recruited from existing descendants. Expression of a proposed reserve marker does not prove that it exclusively labels a quiescent stem-cell population. Drivers can label several states, marker expression can change after injury, and apparent populations can overlap. An ablation-induced contribution from a marker-labelled cell is evidence of regenerative potential in that labelled lineage; it need not reveal its normal developmental position. Labelling before injury and allowing the inducing reagent to clear are essential to avoid marking newly activated cells and mistaking them for the original source.

Committed descendants provide direct evidence for such flexibility. Enterocyte-lineage progenitors labelled through Alpi normally give short-lived absorptive descendants, yet after Lgr5-cell ablation they can produce persistent renewing lineages. ^[ref] This supports intestinal stem-cell plasticity rather than an absolutely one-way hierarchy. It should not be generalized to every mature cell on a villus: a progenitor already biased toward an absorptive fate and a terminally mature enterocyte are different starting populations. Clonal persistence and renewed multilineage output are stronger endpoints than transient expression of one stem-cell marker.

Further work connected recovery of the ablated intestinal stem-cell compartment to Ascl2-dependent dedifferentiation of absorptive and secretory precursors. ^[ref] Regenerative cells can initiate the returning programme before the full usual marker combination is restored. This makes stemness a context-dependent functional state as well as a useful marker-defined category. It also yields a testable limit to compensation: if a required reprogramming regulator is disabled, the presence of alternative surviving cells need not be sufficient for recovery. Targeted perturbation should be assessed alongside precursor survival so that failure to reprogramme is not confused with removal of the proposed source.

Dispensability changes markedly when another injury removes or disables the compensating population. Combining Lgr5-cell depletion with radiation-induced damage caused severe crypt loss and failure of robust regeneration, unlike the relatively preserved homeostasis after depletion alone. ^[ref] This demonstrates conditional necessity in the tested injury regime. It does not create a contradiction with compensation under ordinary maintenance: the two interventions alter different components of the regenerative system. Radiation affects multiple epithelial and niche populations, and its timing relative to ablation and recovery is therefore part of the explanation rather than a minor technical detail.

A factorial experiment makes that logic explicit. Compare control, Lgr5-cell depletion alone, radiation alone, and the combination, with matched ages, intestinal regions and observation times. Include receptor-negative animals receiving toxin, receptor-positive untreated controls, and independent confirmation of cell removal rather than relying solely on loss of the fluorescent reporter. Measure crypt number and clonogenic recovery, epithelial composition, apoptosis, inflammatory or stromal damage and longer-term function. Evidence that surviving untargeted cells generate new stem-cell clones is required to identify the replacement mechanism; normal tissue appearance does not identify the source.

The duration of targeting is also important. A lineage that first lacks the marker but later adopts Lgr5 expression may become sensitive to continued toxin treatment. A pulse of ablation followed by repopulation and sustained elimination of the re-emerging state consequently test different hypotheses. Escaper cells with incomplete receptor expression or recombination can expand after treatment and mimic recruitment from another lineage. Pre-existing lineage labels, spatial imaging and independent ablation strategies help distinguish rare survivors from true conversion, while acknowledging that every strategy can perturb the niche itself.

Finally, removing Lgr5-expressing cells is not equivalent to deleting the Lgr5 gene. The former removes entire cells, including their other molecular functions; the latter changes a receptor while leaving the cells and possible compensating pathways in place. Likewise, demonstrating organoid growth under supplied matrix and growth factors establishes competence under those conditions, not niche independence in vivo. Normal renewal, replacement capacity and receptor requirement must therefore remain separate conclusions.

The evidence supports a plastic, partly redundant renewal system: Lgr5-positive cells are major normal contributors, can be replaced under some maintenance conditions, and can become crucial when injury limits alternative sources. The scientifically useful claim is conditional dispensability of a defined population under a defined protocol, not general irrelevance of those cells or the stem-cell state they exemplify.